Finch Therapeutics
Curated by SignalDeveloper of microbiome-based therapies by using human-first discovery platform
Overview
Finch Therapeutics is a developer of microbiome-based therapies using a human-first discovery platform. It is using proprietary machine learning techniques to build a clinically annotated library of strains that drive clinical phenotypes of interest. It has also developed an AquaShell for targeted delivery of microbial therapeutics. Its products mainly focussed on Inflammatory Bowel Disease (preclinical), and others.
Key facts
- Founded
- 2004
- Headquarters
- Somerville, United States
- Stage
- Sign up to view
- Industry
- Life Sciences Technology
Business model
- 2 products and services
- Sign up to view
Contact
- Primary office
- Sign up to view
- Sign up to view
- Phone
- Sign up to view